Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of ARIPAZ-5 vs ABILIFY 5 mg Tablets Under Fasting Conditions
TCTR20220811003Phase 1Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aripiprazole (2 arms), sponsored by Government Pharmaceutical Organization. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
aripiprazole
Beyond the preview
Go deeper on TCTR20220811003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220811003.